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Stem cells continue to receive widespread attention due to their potential to revolutionise treatments in the fields of both tissue
engineering and regenerative medicine. Adult stem cells, specifically mesenchymal stromal cells (MSCs), play a vital role in the
natural events surrounding bone healing and osseointegration through being stimulated to differentiate along their osteogenic
lineage and in doing so, they form new cortical and trabecular bone tissue. Understanding how to control, manipulate, and
enhance the intrinsic healing events modulated through osteogenic differentiation of MSCs by the use of modified surfaces
and biomaterials could potentially advance the fields of both orthopaedics and dentistry. This could be by either using surface
modification to generate greater implant stability and more rapid healing following implantation or the stimulation of MSCs ex
vivo for reimplantation. This review aims to gather publications targeted at promoting, enhancing, and controlling the osteogenic
differentiation of MSCs through biomaterials, nanotopographies, and modified surfaces for use in implant procedures.
1. Introduction
Biomaterials have advanced significantly in recent years,
although with an aging global population, what was once
deemed to be an acceptable longevity for an implant is no
longer so, driving the development of improved biomaterials
that have superior performance and greater longevity. One
area where this effect is very obvious is in orthopaedic
arthroplasty. It is estimated that by 2030, there will be a
174% increase in the need for total hip replacements (THR)
accompanied by a 674% rise in total knee replacements
(TKR) [1]. Over the same time period, the need for revision
surgery, to surgically replace or repair a failing prosthetic
joint, is also set to increase dramatically. To help reduce
the need for revision surgery, suitable biomaterials must be
developed for these applications based on their mechanical
and biocompatible properties [2]. Ideally for orthopaedic
implants, the material must be mechanically strong enough
to tolerate the load of the joint whilst also having a Young’s
modulus that is suitable to transfer load into the surrounding
tissues. It is also important for the implant material to be
bioinert to prevent any inflammatory response, although
bioactive materials are currently the implant material of
choice [3], as they can promote positive biological responses
such as osseointegration. Osseointegration is important for
bone healing and is the formation of a direct interface
between an implant and bonewithout the need for connective
soft tissue [4, 5]. For the formation of a direct interface to
occur between an implantable biomaterial and native bone
tissue, the recruitment of cells with osteogenic potential must
happen on the surface of the implant. Colonisation by such
cells to the site of interest occurs through the release of
growth factors and cytokines into the clot surrounding the
site of implant placement, and it is widely accepted thatMSCs
are the first osteogenic cells recruited to such sites in vivo
[6, 7]. MSCs are multipotent cells that have the ability to self-
replicate and to differentiate into osteogenic, chondrogenic,
adipogenic, fibroblastic, and neural lineages [8].Through the
release of local factors and interaction with the biomaterial
surface, MSCs ideally can be triggered to differentiate along
their osteogenic lineage, forming osteoblasts capable of facil-
itating bone healing at the implant site. This is triggered
by a complex combination of events, involving cytoskeletal
tension within the cells, cellular membrane signalling, focal
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adhesions, and the secretion of a calcium rich extracellular
matrix (ECM). To improve this cellular response, the implant
surface can be tailored with topographical and chemical cues,
with factors that have been shown to modulate the differenti-
ation of MSCs, including both micro- and nanoscale surface
topographies, along with surface energy and chemistry. This
review aims to examine the use ofmodified surfaces to trigger
and enhance the osteogenic differentiation of MSCs, with the
ultimate aim of creating orthopaedic and dental implants that
support osseointegration and promote more rapid healing.
2. Titanium
Titanium has long been the gold standard for orthopaedic
and dental implants due to its excellent biocompatibility,
corrosion, and wear resistance and its ability to promote
osseointegration at the bone-implant interface [9]. What
helps to trigger the osteogenic differentiation of MSCs on
titanium has been heavily investigated, resulting in the
formation of titanium alloys with modified surfaces aimed
at promoting osseointegration. A titanium implant mate-
rial with a modified surface from Institut Straumann AG
(Waldenburg, Switzerland), known as SLActive, has been
extensively researched in recent years as a method of pro-
moting the osteogenic differentiation of MSCs and in turn
leading to greater levels of osseointegration being observed
after implantation. The novelty of the surface is that it
utilises two elements that have been shown to be important
in engendering good bone responses; the first is a rough
topography optimised for bone response [10], and the second
is high surface energy rendering the surface superhydrophilic
[11, 12]. Buser et al. first demonstrated the bone integration
potential of SLActive in an animal study using aminiature pig
model. Through bone implant contact (BIC) measurements,
SLActive was shown to promote enhanced bone healing
at early stages compared to the nonhydrophilic roughened
surface (SLA) [13]. In similar studies, Schwarz et al. used a
canine model to investigate various levels of bone integration
and again found SLActive superior in the level of bone healing
observed [14–16]. Bornstein et al. utilised a canine model
to investigate bone apposition to both SLActive and SLA
implants. The SLActive surface demonstrated significantly
more bone apposition after twoweeks of healing, highlighting
the surfaces ability to promote accelerated early osseoin-
tegration [17]. In human studies, Lang et al. performed a
dental study involving 49 patients. Implants were inserted
into the retromolar area and following retrieval; the level
of osseointegration observed was superior at 2 and 4 weeks
for SLActive [18]. To gain further understanding of bone
integration on implants at a genetic level, Donos et al.
implanted both SLActive and SLA implants in the retromolar
area of nine human patients. Upon retrieval, analysis of
RNA extracted from the tissues attached to the implants
was performed. SLActive displayed an upregulation in genes
associated with both osteogenesis and angiogenesis 1 week
after implantation. It was concluded that the proosteogenesis
and proangiogenesis influence of the SLActive surfacemay be
responsible for its early osseointegrative superiority [19]. For
a more in-depth review regarding SLActive in vivo studies,
please refer to Schwarz et al.’s recent publication [20].
These in vivo studies demonstrate the bone integration
potential of the SLActive surface although failing to iden-
tify the underlying biological reasoning behind its superior
osseointegration properties. As MSCs have been identified
as a key cell type necessary for osseointegration and bone
healing [6, 7], the cellular response of humanMSCs to SLAc-
tive surfaces, in particular their osteogenic differentiation,
was highlighted as an area of importance. This was initially
studied byWall et al. [21] who utilised both SLActive and SLA
surfaces, along with a smooth titanium surface as a control
(SMO). Wall et al. found that both SLActive and SLA outper-
formed SMO [21], which was expected taking into account
the difference in surface roughness, previously highlighted as
an important factor for bone integration [10]. Levels of RNA
for the osteogenic genes WNTa, BSP, Runx2, and SPP1 were
analysed, and SLActive was observed to express higher levels
of RNA expression for the osteogenic markers examined.The
higher levels of RNA found on the SLActive surface point
to an accelerated osteogenic response from the MSCs and
support the in vivo genetic study discussed earlier [19].
In an attempt to further understand the mechanisms
involved between microstructured titanium surfaces such as
SLActive and the osteogenic differentiation of human MSCs,
Olivares-Navarrete et al. performed a study identifying and
analysing key markers believed to be important in osteogenic
differentiation [22]. It was found that multiple osteogenic
markers were significantly increased on the SLActive surface,
including alkaline phosphatase (ALP), a hydrolase enzyme
responsible for supplying calcium nucleation sites with inor-
ganic phosphate, and early marker of osteogenic differen-
tiation [23]. Osteocalcin (OC), osteoprotegerin (OPG), and
transforming growth factor beta 1 (TGF-𝛽1), late markers for
osteogenic differentiation, were also significantly increased
on SLActive, although vascular endothelial growth factor A
(VEGF-A) was observed to be significantly decreased. The
expression of osteogenic genes was also analysed, and SLAc-
tive was found to upregulate Runx2, OC, ITGA2, and ITGB1
supporting previous publications [19, 21]. Olivares-Navarrete
et al. went on to investigate coculturing combinations of
MSCs with MG63 cells in an attempt to examine if contact
with osteoblast-like cells would have a real-time effect on
the MSC differentiation observed on the Ti surfaces. This
experiment aimed tomimic the in vivo environment allowing
for cross-talk to occur between some of the cell types that
would be present in areas of bone healing. It was found that
local factors released by MG63 cells only had an effect on
the osteogenic phenotype of MSCs grown on the SLA and
SLActive surfaces. WhenMSCs were cocultured with ITGA2
silenced cells, a reduction in the level of osteogenic differenti-
ation was observed on all surfaces, supporting previous work
which highlighted the importance of ITGA2 to osteoblast
response on Ti substrates [24]. DKK2 silenced cells were
also cocultured with MSCs producing similar results on the
SLActive and SLA surfaces, with reduced levels of osteogenic
differentiation being observed from the silenced cell culture.
This also underlined the importance of this factor for the
osteogenic differentiation of MSCs on Ti substrates [25].
Stem Cells International 3
To further examine the SLActive surface, Khan et al.
performed a study investigating certain key bone matrix
components of human MSCs thought to be important for
osteogenic differentiation [26]. Khan et al. hypothesised
that a measure of the level of osteogenic differentiation
occurring could be related to the level of calcium and collagen
deposition in the ECM. The important finding from this
study showed that the amount of calcium deposited per ng
against type 1 collagen was significantly higher on SLActive
suggesting that the quality as well as quantity of bone
deposited was superior on SLActive. The ECM has emerged
as a strong factor in the control of stem cell fate through
physical interactions [27–29], implying that the enhanced
osseointegration properties of the SLActive surface [13–18]
may be due to the stiffness of the calcified ECM [26] human
MSCs produce on the SLActive surface. Khan et al. also
studied ALP expression, the genetic expression of osteogenic
genes Runx2, osteopontin (OP) and bone sialoprotein type 2
(BSP2), and osteogenic protein expression of OC, OPG, and
growth differentiation factor 15 (GDF-15). ALP expression
and early upregulation of osteogenic genes Runx2, OP, and
BSP2 at day 1 again support the evidence that the SLActive
surface promotes an enhanced osteogenic genetic response
fromMSCs [19, 21, 22, 30]. Osteogenic protein expressionwas
analysed over a three-week time course, and both OPG and
GDF-15 were observed to be significantly higher at 3 weeks
on SLActive [26].
3. Nanotopography
Micron scale topographies have been shown to influence
the lineage-specific differentiation of MSCs [21, 22, 26], and
further studies are looking to increase cellular response and
control. The recent emergence of the use of nanotopogra-
phies to control and enhance the differentiation of MSCs
holds great potential in the fields of both orthopaedics
and dentistry. The ability to create various topographies
in either ordered or random formats that can be easily
modified to specific sizes opens up a vast number of
possible uses. Topography-mediated fate determination has
numerous advantages over other techniques used to drive
lineage-specific differentiation. These include an increase
in durability over surface chemistry modification and the
removal for the need of synthetic or biological moieties to
direct differentiation, which have significant regulatory issues
for use in vivo. Surfaces such as the previously discussed
SLActive are on the micron scale in terms of roughness
and topography. Nanotopographies have a distinct advantage
over such surfaces as they have the ability to replicate the
features of tissues found in vivo on the nanoscale. Bone tissues
have features that range from the macro- (osteoids), micro-
(mineralised structures 0.8–1.4𝜇m [31]), and nanoscales
(collagen fibre bundles 5–10 nmwith 67 nm striation and HA
crystals 225 nm [32]). At the nanoscale of bone, a complex
combination of protrusions, fibres, and topographical pits is
present and through interaction with this topography in vivo,
an osteogenic response can be triggered inMSCs, allowing for
the formation of new bone tissue to occur. The research into
materials nanotopography aims to replicate this in vivoMSC
stimulation, controlling the lineage-specific differentiation
of MSCs solely through cellular interactions with material
surface features on the nanoscale.
4. Polymer and Silicon Nanotopographies
Electron beam lithography (EBL) patterned substrates of
polymethylmethacrylate (PMMA), with 120 nm diameter
and 100 nm deep nanopits, were analysed for their effects on
osteogenic MSC fates by Dalby et al. [33]. Ordered patterns
included square (SQ) and hexagonal arrays (HEX), with
disordered patterns including square arrays with pits placed
randomly by up to 50 nm (DSQ50) and 20 nm (DSQ20) on
both axes from their position in a true square array. A final
disordered pattern had pits placed randomly over a 150𝜇m
by 150 𝜇m field (RAND). After 21 days in culture, it was
noted that MSCs on the DSQ50 surface showed areas of
early nodule formation and intense cell aggregation, while
exhibiting regions positive for bone-specific ECM proteins,
OP and OC. At 28 days, mineralisation occurring within
nodules was positively identified, and significantly this only
occurred on the DSQ50 surface. The highly ordered surfaces
(SQ & HEX) showed decreased levels of osteoprogenitor cell
density, andMSCswere fibroblastic in appearance. To further
study the osteogenic potential of the DSQ50 surface, Dalby et
al. performed RNA analysis onMSCs cultured on the DSQ50
surface, against a planar control and a planar material with
the corticosteroid dexamethasone, a chemical additive used
to stimulate the osteogenic differentiation of MSCs. Cells
cultured with dexamethasone had the highest levels of upreg-
ulation with 24 gene hits, although the DSQ50 surface was
able to trigger 11 gene hits in comparison to the controls 3 hits.
Gene expression analysis was then performed for adhesion
molecule ICAM1, signalling molecule receptor TGFBR1 and
the osteogenic genes OCN and ALP. As before, the DSQ50
surface was able to significantly upregulate these important
osteogenic genes, although not to the same level as the
dexamethasone-supplemented cells. Dalby et al. were able to
demonstrate for the first time that disordered nanotopogra-
phies (DSQ50) had the potential to enhance the osteogenic
differentiation of MSCs in the absence of chemical stimuli.
In a follow-up study, Dalby et al. looked at the genomic
expression of human MSCs on two different nanotopogra-
phies created on PMMA [34]. Firstly, surface 40 : 400was cre-
ated via photolithographically producing pits in PMMA, of
dimensions 400 nm depth and 40 𝜇m diameter, comparable
to that of osteoclastic resorption pits found in vivo. Secondly,
via polymer demixing, a surface referred to as 3% : 3000 was
created, producing polymer islands of 33 nm in height, a
surface modification technique previously identified as being
able to stimulate a response from various cell types [35]. It
was found that the topographical surfaces were able to alter
the genomic profile of the MSCs in a similar way to that
of dexamethasone. It was noted that the 3% : 3000 surface
outperformed the 40 : 400. Interestingly some topography
only pathways were noted, such as p38 mitogen-activated
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protein kinase (MAPK), actin cytoskeletal signalling, fibrob-
last growth factor (FGF), and platelet-derived growth factor
(PDGF) [34]. Upregulation of genes ICAM1, TGFBR1, OCN,
andALPwas also observed inMSCs on the test topographies,
supporting Dalby et al.’s earlier observations from the DSQ50
surface, which also initiated an upregulation in some of these
key genes [33].
In a similar study by Biggs et al., PMMA embossing was
used to create disordered nanotopographies of nanocraters
and nanoislands, alongside ordered nanotopographies of pits
arranged in square and hexagonal arrays [36]. Nanocraters
were approximately 47 nm indepthwith 3𝜇mdiameter, while
the nanoislands were approximately 45 nm in height and
3 𝜇m diameter. The ordered arrays were shown to possess
pits of 120 nm diameter with a depth of 100 nm, possessing
a centre-centre spacing of 300 nm. Human MSCs that had
been STRO-1 positively enriched were analysed after being
cultured on the substrates, and it was shown that changes
in the genetic expression of the cells were occurring due
to the topographical features of the substrates. Cell integrin
signalling andmorphology were affected by all the substrates,
although microarray data regarding the greatest number of
modulated gene functions for canonical signalling pathways
was observed from the nanopit arrays. Transforming growth
factor beta (TGF-𝛽) was shown to be upregulated on all
substrates, which for nanoisland substrates was coupled with
a minor upregulation in TGF-𝛽-activated kinase-1 binding
protein (TAB1) and Ca2+/cAMP-response elements binding
protein (CPB).
In a follow-up study, Biggs et al. investigated the effect
nanotopographies have on the ERK/MAPK signalling path-
way for STRO-1+ human MSCs [37]. The signalling cascade,
extracellular signal-regulated kinase (ERK), is a knownmem-
ber of the MAPK pathway, shown to play a significant role in
MSC differentiation [38–40]. Intricate signalling pathways,
such as the ERK/MAPK pathway, play a vital role in the
cellular differentiation of MSCs through translating tensions
applied at the tissue level to cellular functions. Biggs et
al. investigated four PMMA nanotopographies; two nanopit
arrays (SQ & HEX) as previously described [36], and two
groove/ridged arrays, approximately 300 nmdeepwith 10 𝜇m
and 100 𝜇mwidths, respectively. It was found that the ordered
nanopit arrays caused a downregulation in the expression of
multiple signalling molecules, supporting previous research
that highly ordered PMMA arrays restrict the osteogenic
differentiation of MSCs [33]. MSCs cultured on the 10 𝜇m
grooves displayed both up- and down-regulations of sig-
nallingmolecules, although upregulation in the expression of
focal adhesion kinase (FAK) as well as MAPK phosphatases
(MKP) was noted. The 100 𝜇m grooved substrate caused
widespread upregulation in the genes associated with the
ERK/MAPK pathway, alongside significant production of
osteocalcin. Biggs et al. were able to demonstrate through the
use of grooved, ridged nanosubstrates that the ERK/MAPK
signalling pathway could be stimulated for the osteogenic
differentiation of human MSCs [37].
The modulation of human MSC osteogenic differentia-
tion through topographically patterned ridges and grooves on
substrates was further investigated by Watari et al. [41]. Util-
ising silicon substrates, three topographies were studied, each
with grooves 300 nm in depth, but with 400 nm, 1400 nm,
and 4000 nm pitch, respectively. The genetic expression of
Runx2, amaster switch for osteogenic differentiation ofMSCs
[42], was studied after three days in culture, and it was found
that the 400 nm pitch surface stimulated significantly higher
levels of expression than that found on the 4000 nm surface
and planar control. A marker for mature osteoblasts, OCN,
was also examined, and there was a significant topographical
effect in comparison to the planar control. Over a three-
week time course, it was shown that the 400 nm pitch
surface had significantly higher levels of calcium deposition
at days seven and fourteen against the control, a trend
shown before on the larger micron scale with the SLActive
titanium surface [26]. To further examine the effect of the
topographical surfaces, MSCs were then cultured on the
substrates using traditional osteogenic media. The 400 nm
substrate again displayed superior osteogenic properties, with
significantly higher levels of calcium deposition at day 7
and higher Runx2 expression at day 3, in comparison to the
control. Levels of OCN were again observed to be higher
for topographical substrates in comparison to the control. In
osteogenicmedia, it was shown that the 400 nm substrate was
able to significantly increase the level of expression of ID1, a
target gene induced by bonemorphogenetic proteins (BMPs)
[43] belonging to the TFG-𝛽 superfamily thought to play an
important role in osteogenic differentiation of MSCs [44].
This trend was also evident in nonosteogenic media although
not deemed statistically significant. Watari et al. were able
to demonstrate the osteogenic potential of the 400 nm pitch
surface [41], and it was suggested that the surface may have
been superior due to its sizable comparison to the parallel
array of type 1 collagen fibrils located in bone tissue in vivo
[45]. It is important to note that Watari et al.’s conclusions
differed from a previous publication by Yim et al., where
grooved and ridged polymer substrates were shown to cause
neural specific differentiation of humanMSCs [46], although
different coatingmaterials and culturemedia were employed.
In an attempt to investigate the effect of micro- and
nanoscale pillars on MSC differentiation, Brammer et
al. created topographies on gold-coated silicon substrates
[47]. Unlike the previous studies, the substrates were ren-
dered hydrophobic instead of the primarily polymeric and
hydrophilic surfaces. Photolithography and wet etching tech-
niques were used to create micropillar (2.5 𝜇m height, 2 𝜇m
diameter) and nanopillar (2.5 𝜇m height, 20 nm diameter)
topographies, both with spacing proportional to their pillar
diameters. Subsequently, gold deposition was then applied
to keep the surface chemistry constant and focus on the
topographically induced cell response.The nanopillar topog-
raphy was shown to significantly affect the growth of the
rat MSCs while also influencing stem cell fate. MSCs on
the nanopillar topography were shown to have significantly
greater adhesion at 2 hours and increased proliferation at 24
and 48 hours. MSC spreading was hindered at initial stages,
although at three weeks in culture, dense cell aggregates had
formed on the nanopillar surface, and it was hypothesised
that the cells were differentiating due to the morphological
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changes. This hypothesis was based on work by Tang et al.
who studied the relationship between cell-cell interactions
andMSCosteogenic differentiation, where it was found that a
positive linear relationship existed between the two [48]. The
differentiation potential of Brammer’s nanotopographies was
studied, includingmarkers for adipogenesis, chondrogenesis,
and osteogenesis. It was found that the nanopillar topogra-
phy had a higher osteogenic potential through significantly
enhancing the levels of osteogenic mineralisation, detected
by alizarin red staining without the presence of chemical-
inducing additives. High levels of the osteogenic-specific
protein OP detected in the cell aggregates confirmed the
dominant osteogenic properties of the nanopillar topography.
5. Metallic Nanotopographies
As previously discussed, it has been shown that through
the use of nanotopographical influence alone, the osteogenic
differentiation of MSCs can be triggered and stimulated
[33, 34, 36, 37, 41, 47], although the application of such
surfaces still requires further research, in particular, the
transmission of these influential topographies onto load-
bearing implant materials with mechanical and biocompati-
ble properties suitable for dental and orthopaedic application.
As titanium is regarded as the gold standard for orthopaedic
and dental applications [9] due to its excellent biocompat-
ibility and mechanical properties similar to those of bone,
many research groups have targeted the combination of
titanium with nanotopographies tailored for lineage-specific
differentiation of human MSCs.
Sjo¨stro¨m et al. studied the interaction of human MSCs
on titania nanostructures produced on titanium surfaces via
anodisation through a porous alumina mask [49]. Differ-
ent topographies were created via increasing the anodis-
ation voltage, resulting in three different surfaces exhibit-
ing nanopillar structures of 15 nm, 55 nm, and 100 nm in
height, respectively, (diameters 28 nm, 41 nm, and 55 nm).
The topographies created at lower voltages, that is, the 15 nm
and 55 nm surfaces, were described as having densely packed
dot-like structures, in comparison to the 100 nm surface,
which had pillar-like structures with greater centre-centre
distances.TheMSC response on the surfaces showed that the
15 nm high structures sustained well-spread cells with highly
organised cytoskeletons and many large focal adhesions
thought to be important for osteogenic differentiation of
MSCs [50, 51]. In comparison to the other topographies,
the MSC cytoskeletons were less organised with fewer and
smaller focal adhesions. Immunohistochemical staining for
osteogenic markers OC and OP was performed after 21 days
in culture, and it was found that the 15 nm high structures
exhibited bone matrix nodules rich in both OP and OC.
The amount of bone matrix nodules observed decreased
as the titania structures increased from 15 nm to 100 nm,
respectively.
To further examine the osteogenic ability of the 15 nm
structured titanium surface, McNamara et al. performed
a study similar to Sjo¨stro¨m et al. [49], although included
additional techniques aimed at progressing the published
literature [52]. The 15 nm structured titanium surface was
studied against two other structured surfaces, with 55 nm and
90 nm heights, respectively, alongside a planar control. Again
it was shown that the 15 nm structures promoted superior
focal adhesions and an enhanced production of osteocalcin
after 21 days in culture. The transcriptional factor Runx2,
known to be important for the osteogenic differentiation of
MSCs [42], is regulated by differential phosphorylation. After
2 days in culture, it was found that the level of phospho-Runx2
(pS456) in the nuclei of MSCs on the 15 nm surfaces was
enhanced, resulting in an increase in the expression of this
important osteogenic factor.Metabolomics, which studies the
metabolic response of the MSCs, found that a substantial
number of metabolic pathways were upregulated inMSCs on
the 15 nm surface. These included pathways for amino acids,
linoleic acid, and the functional pathway for ALP, known to
play an important role in bone mineralisation [23].
Lavenus et al. studied the influence of nanopores on the
differentiation of human MSCs and the level of osseoin-
tegration observed in an in vivo rat model [53]. Titanium
surfaces were created with nanopores of 20 nm, 30 nm,
and 50 nms via anodisation at 5V, 10V, and 20V in a
combination of acetic and fluorhydric acid. To identify the
osteogenic ability of the nanotopographies, osteoblastic gene
expression was studied without the presence of osteogenic
supplements, and it was found that the Ti30 and Ti50
surfaces promoted early osteogenic differentiation of the
MSCs through up regulation of Runx2 and Col1A1. The
nanosurfaces also seemed to modulate osteogenic factors
ALP, OCN, and BSP. In the in vivo section of Lavenus et al.’s
research, osseointegration of nanostructured implants was
studied in a rat tibia model. After 1 week, it was found that
bone healing was significantly enhanced on nanostructured
implants. Bone tissue was observed to be in direct contact
with the implant; in comparison to the Ti control, a gap of
100 𝜇m was present between the implant surface and host
bone tissue. At week 3, bone contact was clearly evident on
the nanostructured implants with thick trabeculae following
the contours of the surfaces, with the Ti50 surface appearing
to have the highest quantity of bone. BIC values and pull
out tensile tests confirmed the superiority of the Ti30 and
Ti50 surfaces, implying that faster bone healing may have
occurred around these nanostructured implants. Lavenus et
al.’s work is novel for the fact it combines both in vitro and
in vivo results on nanotopographies shown to be influential
on both the osteogenic differentiation of MSCs and in vivo
osseointegration. Although it would have been ideal to study
both in vitro and in vivo tests from the same subject, this
work still shows the osteogenic ability of nanopored titanium
surfaces andmay be extremely influential in future dental and
orthopaedic implants.
Zhang et al. looked at the behaviour and regulatory effects
of rat MSCs on titanium substrates biofunctionalised with
nano-sawtooth structures [54]. Hydrogen peroxide (H
2
O
2
)
was used to fabricate two surfaces with nano-sawtooth
structures different in dimensions, referred to as Ti-6 and Ti-
24. Treatment of H
2
O
2
for 6 hours produced nano-sawtooth
structures with approximate widths of 10 nms and gap dis-
tances (distance between nano-sawteeth) of 100–200 nm. An
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increased treatment time of 24 hours produced the second
surface, which displayed nano-sawtooth widths of 30 nm
and gap distances of 200–300 nm. Under high magnification,
both surfaces showed an interconnected, entangled network
of nanostructures. Cell adhesion and proliferation were
looked at first, and it was found that the large nano-sawtooth
Ti-24 surface had significantly more adhesive cells present
than on the Ti-6 surface and smooth Ti control. Proliferation
was also observed to be enhanced on the Ti-24 surface at time
points 4 and 7 days.The osteogenic ability of the nanosurfaces
was analysed by observing mineralisation, together with
osteogenic gene and protein expression. ALPwas shown to be
more positively pronounced on the nanosurfaces, alongside
enhanced calcium deposition, with the most mineralised
matrix being observed on the large nano-sawtooth Ti-24
surface. Osteogenic genes Runx2, OCN, and OPN were
analysed using real-time qPCR, and it was shown that there
was an upregulation from days 5 to 10 on the nanosurfaces
in comparison to the Ti control, with the large nano-
sawtooth Ti-24 surface promoting the greatest upregulation.
Supporting the genetic findings, the expression of osteogenic
proteins OP and OC was shown to be upregulated on the
nanosurfaces, being strongest on the Ti-24 surface. Using
rat MSCs, Zhang et al. were able to demonstrate that nano-
sawtooth structures on titanium, in particular the Ti-24
surface, have the ability to regulate osteogenesis through
enhancing adhesion, proliferation, and multiple osteogenic
factors involved in differentiation.
The use of TiO
2
nanotubes to control the lineage-specific
differentiation of MSCs was studied by Oh et al., where it was
found that different nanotube dimensions promoted drastic
changes in human MSC behaviour [55]. TiO
2
nanotubes
were fabricated on Ti substrates via anodisation, creating
surfaces with 30, 50, 70, and 100 nm nanotube diameters,
respectively. It was found that smaller diameter nanotubes
elicited cell adhesion but lacked differentiation ability. In
comparison, larger nanotube surfaces promoted cell elon-
gation and osteogenic differentiation, confirmed by positive
staining for OPN and OCN after 21 days in culture, alongside
quantitative real-time PCR gene expression of osteogenic
markers OCN, OPN, and ALP after 14 days incubation. Oh et
al. concluded that the larger diameter TiO
2
nanotube surfaces
(70 nm and 100 nm) were superior for osteogenic differen-
tiation of MSCs by inducing cytoskeletal stresses through
cellular elongation, which were then interpreted into internal
biological responses, triggering osteogenesis within the cells.
As the use of nanotopographies to control and enhance
MSC differentiation is an emerging field of research, it is
unsurprising that different responses to nanosurfaces have
been published. In particular for TiO
2
nanotube modified
surfaces, Oh et al. reported an optimum diameter of 100 nm
[55], where Park et al. have observed cell apoptosis at this
size [56] and identified TiO
2
nanotubes with a diameter of
15 nm to be optimal for cell adhesion and differentiation [57].
In an attempt to further improve the response of MSCs on
TiO
2
surfaces, functionalisation of the surface nanostruc-
tures with growth factors is currently being studied. Park et al.
found that bone-morphogenetic-protein-2- (BMP-2-) coated
TiO
2
nanotube surfaces of 15 nm and 100 nm, respectively,
caused a significantly different cell response [58]. BMP-
2-coated 100 nm TiO
2
nanotubes promoted chondrogenic
differentiation of MSCs, in comparison to the 15 nm BMP-2-
coated nanotubes which enhanced osteogenic differentiation.
Lai et al. performed a similar study with TiO
2
surfaces
(30, 60 and 100 nm) functionalised with BMP-2, although
all surfaces were able to enhance the osteogenic ability of
the surface in comparison with identical uncoated surfaces
[59]. Modification of titanium with TiO
2
nanotubes holds
great potential for influencing MSC behaviour and response,
although further research is required considering the amount
conflicting publications. For an in-depth review regarding
TiO
2
nanotubes for bone regeneration, please see Brammer
et al.’s recent publication [60].
As nanotubes have been identified as an area of interest
in nanotopographies, their combination with microtopogra-
phies has recently been investigated. Zhao et al. used rat
MSCs to examine the level of osteogenic differentiation
occurring on titanium substrates fabricated with micro-
pitted/nanotubular titania topographies [61]. In an effort
to imitate the arrangement of natural bone ECM, several
topographies were created via acid etching and/or anodi-
sation. Anodisation of titanium at 5V and 20V created
surfaces with titania nanotubes of 25 nm and 80 nm in
size, respectively. To create hybrid surfaces with features on
both the micron and nanoscale, acid etching of titanium
was performed, which was then followed by anodisation
at 5V and 20V, creating nanotubes on the micro acid
etched surfaces, denoted as Micro/5VNT andMicro/20VNT.
Controls of both polished (FlatTi) and acid etchedTi (AcidTi)
were included in the study. Proliferation seemed to be largely
unaffected by topography, although higher cell numbers
were present on microsurfaces due to the increased surface
area. The morphology of cells on the modified surfaces
can be related to cellular differentiation [50], with MSCs
located on modified surfaces being extended, polygonal, and
osteoblast-like in appearance, noticeably different from cells
found on FlatTi and AcidTi surfaces, which were small and
resembled fibroblast-like cells. Regarding the ECM, after 2
weeks in culture, collagen formation was found to be denser
on the modified surfaces in comparison to the controls.
Mineralisation of the ECM was analysed by alizarin red
staining, and it was found that all surfaces, apart from FlatTi,
induced the formation of mineralised nodules. To support
the ECM data, the expression of certain osteogenic genes
was analysed. It was found that the topographies induced
different levels of gene expression, although the 20VNT
and Micro/20VNT produced the highest mRNA levels for
important genes such as ALP, OCN, and BSP. This may
be related to mechanotransduction signalling originating
from the cellular extensions and modulated focal adhesions
observed on the Micro/20VNT surface.
This observation of high levels of mRNA for impor-
tant osteogenic genes on micro-/nanotitanium surfaces was
also found by Mendonc¸a et al. [62] using human MSCs.
Using a technique of grit blasting and etching, Mendonc¸a
et al. created a topography on titanium discs which had
both micro and nanofeatures (20–30 nm nanofeatures visible
via SEM analysis). Titanium discs were grit blasted with
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100 𝜇m aluminium oxide particles and then immersed in
an H
2
SO
4
/H
2
O
2
solution to give the surface its secondary
nanofeatures, with the surface being referred to as Nano. A
smooth Ti surface (S) and solely grit-blasted surface (Gb)
were also studied. Real-time PCR was used to measure the
level of mRNA for OCN, OPN, BSP, Runx2, ALP, and Osterix
(OSX) at time points 3, 7, 14, and 28 days. It was found that
at both 14 and 28 days, the Nanosurface was able to threefold
upregulate important osteogenic genes Runx2 and OSX. The
Nanosurface was also able to up regulate OCN (3-fold), ALP
(38-fold), and BSP (76-fold), showing that the surface was
capable of producing an enhanced osteogenic response in
comparison to S and Gb surfaces.
As in Zhao et al.’s [61] and Mendonc¸a et al.’s [62] studies
where the combination of both micron and nanosurface fea-
tures (Micro/20VNTm and Nano) promoted an osteogenic
response, in an attempt to better understand the role different
sizes of surface features have on the osteogenic differentia-
tion of MSCs, Khang et al. performed a study where sub-
nano-, nano-, and submicron surfaces were analysed [63].
Pure titanium was deposited onto glass slips via an e-beam
evaporator, and it was found that surfaces with features on the
nano-submicron range proved to be the most influential on
MSCs. Structures found on this 450 nm thick hybrid surface
had heights of ∼40 nm and widths of ∼250 nm. Osteogenic
genes Dlx5 and OSX were shown to be upregulated in mouse
MSCs after 3 days in culture on the nano-submicron surface,
alongside the upregulation of important osteogenic factors
OC, BSP, OP, and collagen 1. Human MSC response to
titanium surfaces was also studied, and the nano-submicron
surface was again superior, with enhanced adhesion and
proliferation at 6 and 72 hours. Levels of OC, OP, and
osteonectin (ON) were also shown to be enhanced on the
nano-submicron surface. Although the increased surface area
and roughness of the nano-submicron surface can account
for some of the enhanced osteogenic response, the increased
surface structure width may also have caused elongation and
extension of theMSCs, resulting in the transfer ofmechanical
stimuli in the cell cytoskeleton, to osteogenic biological
response.
Using a different surface modification technique known
as surface mechanical attrition treatment (SMAT), Lai et al.
investigated the behaviour of rat MSCs on treated titanium
[64]. Through SMAT, titanium can be fabricated to have a
nanostructured surface, created by serve plastic deformation
of the top layer of a bulk material by means of repeated
multidirectional impact of flying balls. Characterisation of
the surfaces before and after SMAT treatment showed an
increase in roughness from 7.29 nm 𝑅
𝑎
to 29.53 nm 𝑅
𝑎
,
accompanied by a decrease in water contact angle from 66.5∘
to 51.9∘, which is a measure of surface energy, known to be
important for bone integration [11, 12]. The cell morphology
was visibly different on Ti- and SMAT-treated Ti (nano-Ti).
Compared to MSCs on the native Ti surface, MSCs cultured
on the nano-Ti were found to be well spread with well-
developed actin stress fibers. The nano-Ti surface was also
found to promote higher cell viability. To investigate the
ability of the nano-Ti to stimulate osteogenic induction, Lai
et al. looked at ALP activity, ECMmineralisation, osteogenic
proteins, and mRNA expression of important osteogenic
genes. It was found that the nano-Ti surface significantly
enhanced all of these osteogenic factors, with the underlying
mechanism thought to be the expression of OC, OPN,
collagen 1, and Runx2. Lai et al. were able to provide an
alternative method for creating nanotopographies on bulk
titanium, with promising MSC adhesion, proliferation, and
differentiation results. With further work, this surface mod-
ification technique may be capable of enhancing dental and
orthopaedic implants.
6. Conclusion
Modified biomedical surfaces, which have been fabricated
with topographical and chemical cues, have great potential
to direct stem cell fate along a desired lineage. Specifi-
cally for dental and orthopaedic implants, an osteogenic
response from MSCs is desired, stimulating rapid formation
of new bone and osseointegration. In turn, this enhanced
response will lead to shorter healing times of both dental
and orthopaedic devices, due to enhanced MSC osteogenic
differentiation leading to increased early bone apposition
and integration into the implant. Similarly, rapid bone for-
mation should increase early stage stability of the implant,
preventing some failure mechanisms such as micromotion
(a common issue following arthroplasty procedures such as
THR). The use of topography offers the further advantage of
removing the need for chemical stimuli to direct the desired
differentiation which may carry numerous issues for in vivo
application. Through modifying the surfaces of recognised
biomedical implant materials, both the fields of dentistry and
orthopaedics could have the potential to be revolutionised,
by increasing implant efficacy via triggering the osteogenic
differentiation of MSCs.
This review has summarised the results of many studies
showing that the osteogenic differentiation of MSCs can
be achieved without the presence of chemical stimuli via
numerous topographical surface modifications, including
the use of nanopillars, nanotubes, nanopits, nanoislands,
nanocraters, nanogrooves, and nanosawtooth structures,
along with grit blasting/acid etching and SMAT techniques.
What is also prevalent through analysing these studies is
the wide variation of techniques used and occasionally
dissimilar results. This field of research holds great potential
for the possible reduction in healing times after implantation,
although further study is required to clarify which techniques
and specifications are optimal for triggering the osteogenic
differentiation of MSCs. Further, to the in vivo possibilities of
nano-patterned materials, there are also implications for the
ex vivo expansion of stem cells for the use in reimplantation
therapies.
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